BCAT1 is a NOTCH1 target and sustains the oncogenic function of NOTCH1.

Autor: Tosello V; Basic and Translational Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua., Di Martino L; Department of Surgery, Oncology and Gastroenterology, University of Padua., Papathanassiu AE; Ergon Pharmaceuticals, LLC, Washington DC, United States of America., Santa SD; Department of Surgery, Oncology and Gastroenterology, University of Padua., Pizzi M; Surgical Pathology and Cytopathology Unit, Department of Medicine - DIMED, University of Padua., Mussolin L; Unit of Onco-hematology, stem cell transplant and gene therapy, Department of Women's and Children's Health, University of Padua., Liu J; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN., Van Vlierberghe P; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium., Piovan E; Department of Surgery, Oncology and Gastroenterology, University of Padua; Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua. erich.piovan@unipd.it.

Publikováno v: Haematologica [Haematologica] 2024 Sep 05. Date of Electronic Publication: 2024 Sep 05.